Dark Forest Capital Management LP Biohaven Pharmaceutical Holding CO Ltd. Transaction History

Dark Forest Capital Management LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$144.95 - $152.29 $1.24 Million - $1.3 Million	8,521 Added 53256.25%	8,537 $1.29 Million
Q2 2022 Aug 15, 2022	BUY	$83.14 - $145.99 $748 - $1,313	9 Added 128.57%	16 $2,000
Q1 2022 May 13, 2022	BUY	$110.08 - $142.92 $770 - $1,000	7 New	7 $1,000
Q4 2021 Feb 11, 2022	SELL	$99.73 - $148.48 $6,083 - $9,057	-61 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$98.85 - $138.91 $6,029 - $8,473	61 New	61 $8,000

792K

Ticker BHVN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,645,000
Market Cap $2.8B
Description
Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...

Get notified when there are updates to the investment portfolio of Dark Forest Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Dark Forest Capital Management LP with notifications on news.